briefly? -In the methods, (lines 5-7, page 9) the authors state that consent was obtained "additionally from those patients who survived ICU". Does this mean that consent was initially obtained from the next of kin or surrogate, then the patients confirmed consent later, after they had regained decisional capacity? Or were these patients for whom no consent was initially obtained, and they were consented after regaining capacity? Please could the authors clarify? -About the questionnaire, the authors state that it was "designed on the basis of face validity" (page 9, line 23). Could the authors say more about the procedure for designing the questionnaire? What face validity was taken as the basis, and where did the ideas for the items come from? Were the questions taken from group discussions? Were researchers involved in the development of the items? Was the questionnaire tested on a group of active clinical researchers? This is important because I would have some concerns about the formulation of the questions on the questionnaire. In particular, the magnitude of the burden represented by the items should be indicated in the response modality, and not in the question itself. By setting the burden as "huge" in the question, you limit the respondent's capacity to assess the burden by him/herself. I know that it is too late now to do anything about the formulation of the questions, and I am also aware of the problems that arise in translating questionnaires of this type from the original language for publication, but still -the translation seems to clearly indicate that the magnitude of the effect was indicated in the question, which, to me, is questionable. I think that it would be useful if the authors could explain in further detail exactly how they came up with the items in the questionnaire, and describe how it was tested and validated. They might also mention in the limitations that this is an ad hoc questionnaire developed specifically for this study, and not validated. -A further limitation that the authors correctly acknowledge is the fact that this investigation concerned only one specific, ongoing study, namely the DACAPO trial. As the authors are surely well aware, each study is set up in the investigating centres by a different CRO (Clinical Research Organization) acting on behalf of the sponsor, or sometimes by institutional staff from the sponsor organization in the case of academic (non-industry-funded) research. Therefore, there may be wide heterogeneity in the efficacy of study training sessions. This limitation could serve to formulate recommendations for future research -for example, you might suggest that standardized training formats would be useful to ensure optimal efficacy with a view to maintaining high motivation and compliance among the study staff.
Minor remarks: -In the discussion, page 17, lines 9-10: It is not generally acceptable to introduce a new Table in the discussion section. This table should be cited in the results section first -for example, it could be cited in the section about the ECDS (lines 30-46, page 13). -Discussion section, page 16, lines 27-28 -you mention a "recent trination study", but this study was published in 2008, which is not very "recent". I suggest you rephrase and just mention a trination study, or a trination study published in 2008.
-Overall, although the English is legible, there are a number of small grammatical errors that merit correction. For example, we do not say "participate AT" in English, but rather "participate IN". Similarly, you cannot say "between…. Up to …..", but rather "between X AND Y". I would advise the authors to have the paper corrected by a native English-speaking medical writer with experience in scientific publications.
REVIEWER
John Ashurst Kingman Regional Medical Center REVIEW RETURNED 06-Jun-2018
GENERAL COMMENTS
The current manuscript is a research study on a research study of the perceptions of those conducting the project. In order to make this project more generalizable to the masses, the authors need to take a step back from their original project (DACAPO) and look at it from a birds eye view of overall research. I would recommend framing the introduction and discussion more in this format.
Abstract: well written Introduction: Well written but would like to see more a more indepth review of the current literature on researchers attitudes towards research aspects. Last sentence does not make sense in context of the paragraph. Methods: Second paragraph does not make sense for the manuscript. Methods section should focus only on the current study and not the previous study. However, the reviewer does understand an context of the prior study is needed. Was the study beta tested or pre-validated prior to administration? If not, this would be seen as a limitation. From a study perspective, would have liked to have seen a more rigorous distribution method. Would have not allowed the survey to be completed with incomplete responses also Results: Low return rate of surveys, please see above. Remainder is well written. Limitations: Like how the authors mention the low survey returns but personally I would remove the references here. It doesn't add anything to the current data. Also like how the authors note that only their study was studied. Would question about the Hawthorne effect as well. Also, Discussion: supports the results but would like to see a more indepth literature search on researchers beliefs on a given study.
VERSION 1 -AUTHOR RESPONSE
Reviewer 1:
1. Comment (C): "Regarding the participation rate, a total of 169 study personnel were contacted, from (apparently) 65 centres that were participating in the DACAPO study. This is an average of only 2.6 persons per centre, which I find quite low. Usually, in my country at least, there are several investigators listed in each centre for every clinical trial, plus (in larger centres that have the resources to employ dedicated research staff), there is usually also at least one clinical research assistant (CRA) (or study nurse). Could the authors perhaps specify whether it is usual, in Germany, to have CRAs in every centre? Because if we count one CRA per centre, then that leaves only one to two investigators per centre, which I find quite low. Perhaps the authors could comment." "In the same way, almost 70% of respondents were physicians. Here again, in my country, it is unusual for the physicians to enter the study data into the eCRF themselves, this is usually done by the CRAs in each centre. Could the authors also comment on this? Obviously, the situation appears to be different in Germany? (This could go together with the previous comment)."
Answer (A):
In Germany the situation of personal staff for clinical research is very different. For the DACAPO study only 6 of 65 study hospitals (9.2%) had one or more (full time) clinical research assistants or study nurses. We were also surprised that in the intensive care setting and clinical routine (senior) physicians enter data in the eCRFs. We explain these details in the discussion section (page 19, line 10-20) "The increasing workload in intensive care medicine negatively influences the willingness to participate in clinical studies {Cullati 2016 #56}{Smith 2017 #54}. In the systematic preparation of the DACAPO study it was difficult to motivate clinical staff in different kinds of hospitals to take part in an observational study with a high documentation effort and low financial support. On average, only two to three contact persons for each DACAPO study centre were registered in the CSC. More than 70% of survey participants reported that physicians were responsible for data collection and documentation. Only 20 of 65 participating study centres (30.8%) of the DACAPO study permanently employed study nurses or clinical research assistants. This fact could explain the low proportion of study nurses in this survey and shows one option to improve the German research structure in the ICU setting."
2.
C: "Again, on the topic of the respondents, the authors report that they had 75 complete questionnaires available for analysis from 65 centres -how many centres had at least one respondent? It would be interesting to know how many of the centres are represented among these 75 responses. Please could you give this information briefly?"
A:
The anonymous online survey design does not allow giving information about the participation rate of each study centre. We include this fact in the limitations. On the basis of your suggestion, we additionally analysed the response rates of the different survey participations and included them in the results and discussion section.
"The anonymous online survey design does not allow giving information about the participation rate of each study centre." (limitations section, page 20, line 15 to 16) "The online survey response rate was 40% (54 of 135) for physicians and 58.1% (18 of 31) study nurses." (results section, page 13, line 8) "One explanatory approach is the different attitude of physicians and nurses towards research aspects and therapeutic measures in intensive care units. The response rate in this survey was higher for study nurses as for physicians." (discussions section, page 19, line 55)
3.
C: "In the methods, (lines 5-7, page 9) the authors state that consent was obtained "additionally from those patients who survived ICU". Does this mean that consent was initially obtained from the next of kin or surrogate, then the patients confirmed consent later, after they had regained decisional capacity? Or were these patients for whom no consent was initially obtained, and they were consented after regaining capacity? Please could the authors clarify?" A: Following the guidelines of the ethics commissions in Germany, we used a two tier consent procedure. Consent was primarily sought from a next of kin, since the patients were usually not able to consent. Consent from patients was then confirmed later, after they had regained decisional capacity. We explained it more exactly in the methods section (page 9, line5-7). "Written informed consent for participation in the DACAPO-study was obtained primarily from next of kin/caregivers/legal guardians of patients and additionally later from those patients who survived ICU and regained their decisional capacity."
4.
C: "About the questionnaire, the authors state that it was "designed on the basis of face validity" (page 9, line 23). Could the authors say more about the procedure for designing the questionnaire? What face validity was taken as the basis, and where did the ideas for the items come from? Were the questions taken from group discussions? Were researchers involved in the development of the items? Was the questionnaire tested on a group of active clinical researchers? This is important because I would have some concerns about the formulation of the questions on the questionnaire. In particular, the magnitude of the burden represented by the items should be indicated in the response modality, and not in the question itself. By setting the burden as "huge" in the question, you limit the respondent's capacity to assess the burden by him/herself. I know that it is too late now to do anything about the formulation of the questions, and I am also aware of the problems that arise in translating questionnaires of this type from the original language for publication, but still -the translation seems to clearly indicate that the magnitude of the effect was indicated in the question, which, to me, is questionable. I think that it would be useful if the authors could explain in further detail exactly how they came up with the items in the questionnaire, and describe how it was tested and validated. They might also mention in the limitations that this is an ad hoc questionnaire developed specifically for this study, and not validated."
A: Thank you for the critical evaluation. We give more specific information's for the questionnaire developing process in the methods section and the limitations.
"During this process, the research team which comprised psychologists, physicians and health services researchers subsequently modified the questionnaire based on repeated group discussions and the questionnaires were pilot tested on a group of clinical researchers." (Methods section, page 9, line 23).
"An ad hoc questionnaire was developed specifically for this survey. Face and content validity were ensured by repeated group discussions among the research team and a pilot test with a group of clinical researchers'. Formal clinometric validation was not carried out." (Limitations, page 20, line 15) 
5.
C: "A further limitation that the authors correctly acknowledge is the fact that this investigation concerned only one specific, ongoing study, namely the DACAPO trial. As the authors are surely well aware, each study is set up in the investigating centres by a different CRO (Clinical Research Organization) acting on behalf of the sponsor, or sometimes by institutional staff from the sponsor organization in the case of academic (non-industry-funded) research. Therefore, there may be wide heterogeneity in the efficacy of study training sessions. This limitation could serve to formulate recommendations for future research -for example, you might suggest that standardized training formats would be useful to ensure optimal efficacy with a view to maintaining high motivation and compliance among the study staff."
A: Thank you for the useful information. We have included your suggestion in the limitations section.
"For future research standardized training formats would be useful with a view to maintaining high motivation and compliance among the study staff." (Limitations section, page 20, line 50)
6.
C: "In the discussion, page 17, lines 9-10: It is not generally acceptable to introduce a new "The items of the DACAPO eCRFs are described in table 3. The items pertain to six sections: inclusion and exclusion criteria, time of admission on ICU and diagnosis of ARDS, informed consent of next of kin/caregivers, sociodemographic status, discharge of ICU/death of study patient and conclusion with informed consent of surviving study patients."
7.
C: "Discussion section, page 16, lines 27-28 -you mention a "recent trination study", but this study was published in 2008, which is not very "recent". I suggest you rephrase and just mention a trination study, or a trination study published in 2008."
A: We delete the word "recent".
8.
C: "Overall, although the English is legible, there are a number of small grammatical errors that merit correction. For example, we do not say "participate AT" in English, but rather "participate IN". Similarly, you cannot say "between…. Up to …..", but rather "between X AND Y". I would advise the authors to have the paper corrected by a native English-speaking medical writer with experience in scientific publications."
A: Thank you for the critical grammatical revision. The final version of this revised manuscript was corrected by a native English speaker.
Reviewer 2:
1.
Comment (C): "Introduction: Well written but would like to see more a more indepth review of the current literature on researchers attitudes towards research aspects. Last sentence does not make sense in context of the paragraph." Answer (A): We included more current literature and integrated the last sentence in the beginning of the introduction.
"The conduct of multicentre observational studies is associated with a high workload of the researchers regarding recruitment, obtaining informed consent and capturing baseline and long-term follow up data {Weled2015 #3}{Cullati 2016 #56}."
2.
C: "Methods: Second paragraph does not make sense for the manuscript. Methods section should focus only on the current study and not the previous study. However, the reviewer does understand a context of the prior study is needed. Was the study beta tested or prevalidated prior to administration? If not, this would be seen as a limitation. From a study perspective, would have liked to have seen a more rigorous distribution method. Would have not allowed the survey to be completed with incomplete responses also"
